Patrick Schummer

761 total citations
14 papers, 87 citations indexed

About

Patrick Schummer is a scholar working on Dermatology, Oncology and Molecular Biology. According to data from OpenAlex, Patrick Schummer has authored 14 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Dermatology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Patrick Schummer's work include Cutaneous lymphoproliferative disorders research (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Patrick Schummer is often cited by papers focused on Cutaneous lymphoproliferative disorders research (4 papers), Cutaneous Melanoma Detection and Management (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Patrick Schummer collaborates with scholars based in Germany, Austria and United States. Patrick Schummer's co-authors include Anja Gesierich, Bastian Schilling, Melanie Kappelmann‐Fenzl, Silke Kuphal, Lily Vardimon, Anja‐Katrin Bosserhoff, Matthias Goebeler, Hermann Kneitz, Marthe‐Lisa Schaarschmidt and Sebastian Haferkamp and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Cancers.

In The Last Decade

Patrick Schummer

11 papers receiving 84 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Schummer Germany	5	56	39	21	17	14	14	87
Kevin Hu United States	7	40 0.7×	30 0.8×	4 0.2×	18 1.1×	15 1.1×	11	100
María Jesús Rubio-Pérez Spain	6	86 1.5×	31 0.8×	21 1.0×	17 1.0×		15	137
Elena J. Orlando United States	6	115 2.1×	46 1.2×	26 1.2×	19 1.1×		10	138
M. Di Katie Sebastiano Italy	5	26 0.5×	81 2.1×	6 0.3×	5 0.3×	5 0.4×	9	121
Jérôme Paillassa France	6	38 0.7×	18 0.5×	23 1.1×	8 0.5×		20	78
Jaime Mateus-Tique United States	3	58 1.0×	24 0.6×	63 3.0×	5 0.3×		3	107
Xiaohang Yang China	7	35 0.6×	38 1.0×	8 0.4×	10 0.6×	2 0.1×	21	122
Sophie E. Willis United Kingdom	3	76 1.4×	72 1.8×	16 0.8×	6 0.4×		7	99
Enyu Dai United States	2	50 0.9×	43 1.1×	24 1.1×	4 0.2×		5	94
Julia Han Noll Germany	4	56 1.0×	35 0.9×	37 1.8×	3 0.2×		6	92

Countries citing papers authored by Patrick Schummer

Since Specialization

Citations

This map shows the geographic impact of Patrick Schummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Schummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Schummer more than expected).

Fields of papers citing papers by Patrick Schummer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Schummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Schummer. The network helps show where Patrick Schummer may publish in the future.

Co-authorship network of co-authors of Patrick Schummer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Schummer. A scholar is included among the top collaborators of Patrick Schummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Schummer. Patrick Schummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schummer, Patrick, Philipp Schrüfer, Gábor Dobos, et al.. (2025). Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis. JDDG Journal der Deutschen Dermatologischen Gesellschaft.

Glutsch, Valerie, Patrick Schummer, Ann‐Cathrin Koschker, Matthias Goebeler, & Marion Wobser. (2024). Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series. Acta Dermato Venereologica. 104. adv19672–adv19672.

Albrecht, John D., Susanne Melchers, Christel Weiß, et al.. (2024). Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients. Journal of the European Academy of Dermatology and Venereology. 38(5). 954–966. 1 indexed citations

Glutsch, Valerie, Patrick Schummer, Matthias Goebeler, Anja Gesierich, & Bastian Schilling. (2024). Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma. Frontiers in Immunology. 15. 1495004–1495004.

Schummer, Patrick, Valerie Glutsch, Mathias T. Rosenfeldt, et al.. (2023). Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study. SHILAP Revista de lepidopterología. 1. 100003–100003. 1 indexed citations

Peitsch, Wiebke K., Tatiana Görig, Sylke Schneider‐Burrus, et al.. (2022). Patientenpräferenzen bei Hidradenitis suppurativa (APProach‐HS): ein “Discrete‐Choice”‐Experiment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(11). 1441–1454. 1 indexed citations

Peitsch, Wiebke K., Tatiana Görig, Sylke Schneider‐Burrus, et al.. (2022). Patient Preferences in Hidradenitis Suppurativa (APProach‐HS): a discrete choice experiment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(11). 1441–1452. 5 indexed citations

Wobser, Marion, Patrick Schummer, Silke Appenzeller, et al.. (2022). Panel Sequencing of Primary Cutaneous B-Cell Lymphoma. Cancers. 14(21). 5274–5274. 3 indexed citations

Glutsch, Valerie, Patrick Schummer, Hermann Kneitz, et al.. (2022). Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer. 10(11). e005930–e005930. 19 indexed citations

10.

Weber, Judith, et al.. (2020). Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma. European Journal of Dermatology. 30(5). 629–631. 2 indexed citations

11.

Schummer, Patrick, Bastian Schilling, & Anja Gesierich. (2020). Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?. American Journal of Clinical Dermatology. 21(4). 493–504. 31 indexed citations

12.

Thiem, Alexander, Patrick Schummer, Andreas Kerstan, et al.. (2018). Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors. Melanoma Research. 28(5). 465–468. 3 indexed citations

13.

Thiem, Alexander, Hermann Kneitz, Patrick Schummer, et al.. (2017). Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab. Acta Dermato Venereologica. 97(10). 1252–1254. 4 indexed citations

14.

Schummer, Patrick, Silke Kuphal, Lily Vardimon, Anja‐Katrin Bosserhoff, & Melanie Kappelmann‐Fenzl. (2016). Specific c-Jun target genes in malignant melanoma. Cancer Biology & Therapy. 17(5). 486–497. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact